|
HS Code |
519443 |
| Product Name | Glycyl-Proline-7-Amino-4-Methylcoumarin Hydrobromide |
| Cas Number | 93515-18-7 |
| Molecular Formula | C16H20BrN3O4 |
| Molecular Weight | 398.26 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water and DMSO |
| Storage Temperature | -20°C (recommended) |
| Purity | Typically ≥98% (HPLC) |
| Synonyms | Gly-Pro-AMC Hydrobromide |
| Usage | Biochemical substrate for enzyme assays |
| Spectral Properties | Excitation: ~350 nm, Emission: ~440 nm |
| Stability | Stable under recommended storage conditions |
As an accredited Glycyl-Proline-7-Amino-4-Methylcoumarin Hydrobromide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Glycyl-Proline-7-Amino-4-Methylcoumarin Hydrobromide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Glycyl-Proline-7-Amino-4-Methylcoumarin Hydrobromide shows up in the lab as a reliable substrate for identifying enzyme activity, especially with prolyl endopeptidases and related peptidases. This compound, often cataloged under model number GP-7AMC-HBr, plays a distinct role in peptide research. Across my years handling biochemical reagents, I have seen countless attempts to tune measurement sensitivity, and many enzymes still slip past standard screens. GP-7AMC-HBr creates a fluorescence signal right where the researcher needs it, giving a stronger, cleaner readout. That subtle jump in lab clarity can mean less guesswork, shorter experiment times, and more confidence in your data. Higher accuracy doesn't just save time; it cuts costs. In environments where reproducibility gets questioned, GP-7AMC-HBr gives experiments a fairer shot at meeting rigorous publication standards.
This molecule marries the Glycyl-Proline dipeptide to the fluorogenic tag 7-Amino-4-Methylcoumarin (AMC), delivered as a hydrobromide salt to improve its stability and solubility. Its setup means enzymes chop the bond, releasing the AMC group. Whenever an enzymatic cleavage happens, you get a clear pulse of fluorescence—easy to catch and quantify with basic fluorometers set around an excitation of 360 nm and emission near 440 nm. I’ve worked with plenty of substrates that give murky colorimetric changes or fade over time, and AMC-based substrates consistently outshine those traditional picks, especially for real-time kinetic studies. There's no fiddling around hoping to catch the endpoint.
In actual use, this matters. Junior researchers can visually track reactions, watching bright blue on their plates—no need to squint or wait for results. Whether applied in brain enzyme mapping, drug metabolism screening, or process optimization, the improvements ripple out. Mistakes shrink, repeat runs drop, and experienced technicians spend less time double-checking what "develops" versus what is simply noise. That's a big relief when publication deadlines or patient samples start piling up.
Some labs swear by colorimetric or generic peptide substrates. They cost less, yes, but I’ve watched them miss discrete enzymatic activities, leading to re-tests. And those missed targets? Sometimes they matter—a lot. An AMC-linked substrate like Glycyl-Proline-7-AMC-HBr raises the detection bar. Try measuring low-abundance peptidases in complex tissue; background junk climbs fast with basic nitroanilide or chromogenic dyes. AMC tags light up only when cleaved, and that sharp on-off signal slices through murky samples. In projects involving neurobiology or metabolic profiling, I find that using this compound once often pushes a facility to rethink its substrate budget.
Beyond sensitivity, GP-7AMC-HBr sticks out for specificity. The dipeptide sequence, Gly-Pro, limits false positives by matching known enzyme preferences in many physiological systems. That targeted approach means your data stays relevant and actionable rather than clouded by stray protease activity. Many researchers start with a broader pool, using standard fluorogenic peptides, but eventually switch to Glycyl-Proline derivatives to drop false alarms. Having sorted through hundreds of enzyme assays over years and learning which signals pan out, you come to trust compounds that waste less bench time.
GP-7AMC-HBr lands in neuroscience, pharmacology, aging research, and even plant biology. It's a common feature in high-throughput screening setups—its fluorescence adapts easily to both 96- and 384-well formats. I've seen entire screening campaigns rely on it for tracking prolyl endopeptidase inhibitors, hoping to slow down age-related peptide degradation. Taking this substrate into classrooms, undergrads pick up basics in real enzymology thanks to its simple, visible output. For postdocs or core facility staff, multiplexing is smoother owing to the narrow fluorescence window—fewer overlapping signals muddy the readout, so you can dose or inhibit multiple targets at once.
Where GP-7AMC-HBr stands apart: data interpreted quickly and skillfully. I've watched graduate students breeze through notebook checks, pointing to unmistakable peaks instead of arguing over faint, hard-to-interpret bands. In multi-step syntheses or multi-target screens, this clarity helps avoid spiraling costs and schedule slips. More grant-funded core labs now stock AMC substrates as their baseline option, nodding to the hours they claw back simply by shedding ambiguous chemistry.
Enzyme-based diagnostics carry huge weight for patient outcomes. Glycyl-Proline-7-AMC-HBr’s precision lets pathology labs move from ambiguous, technician-dependent color tests to sharp machine-read fluorescence. In clinics chasing ultra-sensitive indicators—early signs of inflammation, cancer-related protease activity, or metabolic disorders—this compound's rapid, unequivocal readouts simplify interpretation. Physicians get answers sooner. As someone who’s worked with hospital lab techs, the priority isn't a fancy chemical name—it's cut-and-dried calls: elevated, normal, or abnormal. With this tool, labs avoid inconclusive data that holds up diagnoses or treatment decisions.
The science community increasingly demands data that can be checked, repeated, and shared. Using substrates like Glycyl-Proline-7-AMC-HBr, labs log numeric fluorescence rather than squishy visual estimates. Results get graphed, not guessed. Over years of referencing published protocols or troubleshooting failed replications, I know datasets produced with AMC substrates speed up peer review and reduce reviewer pushbacks. Sharing raw fluorescence numbers creates cleaner cross-lab collaborations, raising overall trust in shared findings. This transparency ensures a stronger feedback loop with the public and regulators, who keep a wary eye on anything affecting health or pharmaceutical claims.
Improperly stored reagents can throw off months of results. GP-7AMC-HBr’s hydrobromide salt form, though more stable than some derivates, still benefits from thoughtful storage. Refrigerate, avoid moisture, and keep out of direct light—basic advice, but after years retrieving ruined vials from communal fridges, I remind anyone handling it: fresh stocks help nail down enzyme rates without wondering whether last week’s peak depended on degraded material. The hydrobromide also dissolves efficiently in DMSO or water, letting you prep working stocks on-demand. That means fewer freeze-thaw cycles and less waste—something core managers and grant budgets both appreciate.
Large collaborative projects need substrates that don't shift with every new lot. Batch-to-batch consistency determines whether today's data match last quarter's runs. I've heard frustration in multi-center studies when substrates from different suppliers yield diverging enzyme rates. GP-7AMC-HBr, especially when sourced from established chemical suppliers, tends to uphold strict material identity. Labs invested in comparative studies or multicenter trials should maintain internal reference standards and consider joint validation checks, confirming that the “same” substrate from different batches continues producing predictable results. That translates to smoother regulatory submissions and less revision between funding cycles.
Fluorogenic substrates create less hazardous chemical waste than heavy-metal based dyes. With environmental regulation tightening, GP-7AMC-HBr’s breakdown products place less burden on disposal systems. In university settings with strict effluent monitoring, switching to AMC-based assays means fewer red flags from environmental health and safety officers. For labs in countries with less developed chemical disposal infrastructure, safer waste management preserves downstream waterways and working conditions. Having spent years helping audit chemical usage, I see a clear trend: safer, more stable substrates help research groups adapt to evolving regulations and shrinking budgets for hazardous disposal.
Industry screens thousands of compounds weekly, needing chemical reagents that hold up over countless cycles. GP-7AMC-HBr’s robust fluorescent signal and predictable cleavage profile let high-throughput platforms automate readings with little calibration between plates. Colleagues in pharma R&D value substrates that minimize downtime—a faulty batch or unreliable readout cascades into delayed candidate selection, leading to missed milestones or costly reruns. Engineers often tune substrate concentration, adjusting signal optimization for robots and automated plate readers. With a background running mid-scale prep labs, I’ve found Glycyl-Proline-7-AMC-HBr suits pilot production up to full GMP-compliant settings, simply by scaling input amounts and keeping an eye on purity at each step. That reliability takes stress out of scale jumps.
Any research-grade chemical faces challenges in uptake and acceptance. Price can slow adoption, especially in lower-budget labs. Community-led purchasing alliances, seen with academic consortia, give researchers collective leverage to negotiate lower costs. Peer-shared protocols help labs stay current with best practices, reducing the risk of failed runs. Increased transparency from suppliers—batch certificates, impurity profiling, and usage guidelines—also builds confidence in switching over to GP-7AMC-HBr. Avoiding vendor lock-in matters, too; open-source assay designs and inter-institutional benchmarking projects keep competition healthy and labs free from single-point failures.
Fields like synthetic biology and personalized medicine shift quickly. New therapeutic targets often demand enzymes with tough-to-measure activity profiles. Glycyl-Proline-7-AMC-HBr adapts to novel screening challenges thanks to its clean signal and substrate selectivity. In my work with next-generation sequencing teams and custom protein engineering groups, the compound consistently enables detailed breakdowns of protease specificity and substrate turnover. As society’s focus turns toward individualized therapies, measurement standards built on solid, reproducible chemistry become even more crucial. Tools allowing teams to pivot fast, without losing signal truthfulness, keep basic research relevant to real-world applications.
Scientific progress depends on how readily students and early-career scientists access proven techniques. Using clear, responsive substrates in teaching settings lets newcomers build intuition around enzyme dynamics. In the teaching labs I’ve organized, simple fluorescence plates supported by Glycyl-Proline-7-AMC-HBr demystify protease assays. Skill-building becomes more inclusive; class members discuss results, spot patterns, and troubleshoot with less hesitation. Widespread access builds a more robust pipeline of technical talent willing to take on complex biochemical puzzles, laying the groundwork for improvements in both research and applied medicine.
Transparency builds the backbone of trust between the public, researchers, and regulatory bodies. Glycyl-Proline-7-AMC-HBr’s measurable, reproducible fluorescence creates fewer opportunities for ambiguity in scientific conclusions. Detailed readouts mean that peer reviewers, faculty advisors, and outside auditors can trace experimental outcomes to discrete, quantitative changes rather than subjective judgments. My direct experience with review panels shows that solid, reference-backed data built upon validated substrates speeds manuscript approval and eases cross-institutional collaborations, ensuring that scientific discourse moves forward based on clearer evidence and shared standards. In this age of skepticism around data reliability, tools making claims indisputable serve a vital social good.
Discoveries thrive where experimental risk is managed, not avoided. Substrates with high specificity and strong, interference-free signals like Glycyl-Proline-7-AMC-HBr allow scientists to test bold hypotheses with less fear of data misreading. I’ve planned screens where rare enzyme activities or low-expression proteins demanded every edge in measurement clarity. AMC-based substrates prevent wasted weeks on false leads, letting teams allocate resources toward genuinely promising directions. As funding sources tighten and publication standards rise, risk reduction moves from luxury to necessity, letting research groups pursue new ideas without constant worry about chasing technical mirages.
Glycyl-Proline-7-Amino-4-Methylcoumarin Hydrobromide advances daily scientific work by making complex enzymatic measurements more straightforward, more reliable, and more accountable. By offering an edge in clarity, specificity, and reproducibility, it gives both small academic groups and large industry teams the tools they need to generate impactful, trusted data. It’s that on-the-ground reliability—rooted in years of practical feedback, adaptation to changing needs, and responsiveness to regulatory pressures—that keeps this compound at the center of smart assay design and resilient lab practices. Peering ahead, those who invest in solid, transparent measurement technologies will outpace the inevitable hurdles thrown up by evolving science, shrinking budgets, and rising expectations.